Vincent O'Neill, See Remarks at BioXcel Therapeutics, Inc. (BTAI), sold 155 shares at $1.29 ($200) on 2024-06-17, disclosed to the SEC on 2024-06-18.
Scheduled sale ($200) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BTAI | SELL | 2024-09-17 | $95 | — | Filing → |
| BTAI | SELL | 2024-04-08 | $432 | — | Filing → |
| BTAI | SELL | 2023-03-16 | $17K | — | Filing → |